News-Medical.Net on MSN1d
C. diff uses toxic compound to gain competitive advantage in the gut
The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills ...
Medscape29d
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections
[Optimer, Unpublished data]. Box 1. Guidelines for current treatment of Clostridium difficile infection. Antiperistaltic agents and opiates should be avoided. In general, strive to use ...